Federal Awards · Award

4570643447!NASAL DECONGESTANT 30 MG TAB 24S

Award details are derived from public USAspending.gov records. Not a bid recommendation.

Award details

Award ID: SPE2DR26FCCFS
Contractor
Awarding agency: Department of Defense
Sub-agency / office: Defense Logistics Agency
Award amount: $30
Period of performance: Jan 21, 2026 – Jan 22, 2026
NAICS: 325411 — Medicinal and Botanical Manufacturing
PSC: PSC 6505
Place of performance: IL
Parent award: SPE2DR25D9979

Public award description

Source: USAspending.gov

Find out who's winning similar federal contracts

Discover comparable awards, related contractors, and agency purchasing history.

Related intelligence

Related Federal Awards

Same agency and NAICS · SPE2D826F22C1 — 4572303799!PV PHARM BRANCH, VENDOR, CAGE 0U9U0 · Department of Defense · $156,233
Same agency and NAICS · SPE2D826F22C3 — 4572303695!PV PHARM BRANCH, VENDOR, CAGE 0U9U0 · Department of Defense · $131,480
Same agency and NAICS · SPE2D826F22C2 — 4572303802!PV PHARM BRANCH, VENDOR, CAGE 0U9U0 · Department of Defense · $130,995
Same agency and NAICS · SPE2DR26FBCLK — 4572302804!ALTEPLASE 100MG VI 1S · Department of Defense · $62,640
Same agency and NAICS · SPE2D826F22C4 — 4572303766!PV PHARM BRANCH, VENDOR, CAGE 0U9U0 · Department of Defense · $61,910
Same agency and NAICS · SPE2D826FA9NS — 4572303874!PV PHARM BRANCH, VENDOR, CAGE 0U9U0 · Department of Defense · $39,198

Browse federal awards · Browse contractors

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

SmartSolo ChatGPT Claude Perplexity Grok Gemini

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.